Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Researchers at Stanford University have made significant strides in stroke treatment by developing an innovative technology that enhances the effectiveness of existing methods. This breakthrough, known as the milli-spinner thrombectomy, shows promise for improving patient outcomes, especially for those experiencing strokes, heart attacks, and other clot-related conditions.
Blood clots form when thread-like proteins called fibrin clump together. The milli-spinner thrombectomy operates using a hollow rotating tube featuring specialized fins and slits. This device is introduced into the body via a catheter, where it applies both force and suction to target and reduce the size of the clot.
Remarkably, this process can shrink a blood clot to as little as five percent of its original volume without severing the fibrin threads. Preventing the breakage of these threads is crucial, as fragmenting the clot could lead to dangerous pieces traveling to hard-to-reach areas within the body, as noted by the researchers.
The milli-spinner allows for the release of red blood cells while effectively extracting the considerably smaller fibrin clot without the risks associated with other methods. The technology’s innovative approach aims to address the limitations of current treatments.
Renee Zhao, the senior author and assistant professor of mechanical engineering, noted that traditional methods depend on deforming and rupturing the clot. She emphasized that there has been no way to reduce the clot’s size in existing technologies.
“What makes the milli-spinner unique is its ability to apply compression and shear forces that minimize the volume of the clot without causing rupture,” she explained.
The Urgency of Effective Treatment
Timeliness is critical when responding to an ischemic stroke, which occurs when a clot obstructs blood flow to the brain. Research indicates that every minute lost during a stroke results in the destruction of 1.9 million brain neurons and 14 billion synapses.
Despite advances in technology, current devices only succeed in removing clots about half of the time on the first attempt, with a complete failure rate of approximately 15%. Zhao and her colleagues have set out to remedy these shortcomings.
Co-author Jeremy Heit, chief of neuroimaging and neurointervention at Stanford, highlighted the significant improvements achieved with the milli-spinner. “In the majority of cases, our technology more than doubles the effectiveness of current methods,” Heit stated. “For particularly difficult clots, where traditional devices succeed only 11% of the time, we have been able to open the artery on the first attempt up to 90% of the time.”
He concluded that this technology represents a major advancement that could dramatically enhance the ability of healthcare professionals to assist patients in critical situations.
Research Findings and Future Applications
The research team’s findings, which included both animal studies and advanced machine-based flow models, were published on June 4 in the journal Nature. Their results paint a hopeful picture for the future of thrombectomy procedures.
In addition to stroke treatment, the milli-spinner could potentially find applications in other medical fields, such as the removal of kidney stone fragments, showcasing its versatile capabilities.
Currently, the research team is focused on obtaining clinical approval for their innovative technology, with clinical trials anticipated to commence shortly.
“What makes this technology truly exciting is its unique mechanism to actively reshape and compact clots rather than simply removing them,” Zhao noted. “We are diligently working toward introducing this technology into clinical settings, where it could greatly increase the success rates of thrombectomy procedures and ultimately save lives.”
Looking Ahead
The introduction of the milli-spinner thrombectomy stands as a beacon of hope in the medical community. Researchers are optimistic about the technology’s ability to change the landscape of stroke treatment and help countless patients recover from life-threatening conditions.
As the team continues to work on clinical trials, the medical field eagerly anticipates the outcomes. The development is not only a testament to the power of scientific innovation but also a reminder of the ongoing quest for improved medical solutions across various disciplines.
Healthcare providers and patients alike are hopeful that such advancements will enhance treatment capabilities and lead to better prognoses in critical health situations. This potential breakthrough may soon redefine how strokes and other clot-related ailments are treated, ultimately paving the way for a healthier future.
With ongoing research and enthusiastic support from the medical community, the milli-spinner thrombectomy could very well revolutionize the standard of care in the realm of emergency medicine.
